Cancer Active
Cancer Prevention Cancer Treatment Support Us Online Shop
Chris Woolmams / Catherine Woollams
New test to distinguish fast from slow growing prostate cancers

While almost 95 per cent of prostate cancer is slow growing and found in males above 60 years, some 5 per cent is fast growing and was typically found in younger men.

Unfortunately, with a six-fold increase in forty-something males developing the disease, old lines of fast/slow growing have become blurred with the risk that doctors start treating cancers that, if left alone, would never cause a problem. Hitherto, the only way of deciding fast versus slow growth was a less than perfect Gleeson score.

Now a new test from Genomic Health has been developed aiming to save men unnecessary treatment.

Results of a study assessing the prostate test’s performance were presented at the annual meeting of the American Urological Association in San Diego.

‘It’s very hard to tell a surgeon I’d like to leave a cancer in place,’ said Dr. Jonathan Simons, president of the Prostate Cancer Foundation, a research and advocacy organization. Dr. Simons, who was not involved in the study, said the development of new genetic tests like the one from Genomic Health represented a “watershed,” akin to going from pulse rate measurements to electrocardiograms in cardiology.

Some experts said it was too early to assess how accurate the test really was and whether it would make a difference in men’s decisions. A new decision maker is increasingly involved in America – the Insurance company. They will want to know about accuracy before they cough up the money ($3,820 per test!).

Even the senior investigator of the study, Dr. Peter R. Carroll, said he was not sure.

The new test, which is called the Oncotype DX Prostate Cancer Test, is one of more than a dozen coming to market that use advanced genetic methods to help better manage prostate cancer. The most direct competitor to the Oncotype test is likely to be the Prolaris test, introduced last year by Myriad Genetics.

But Genomic Health’s test has attracted attention because of the company’s track record. It already sells a similar test for breast cancer, Oncotype DX Breast Cancer, which is widely used in America (if not in the UK) to help women decide if they need chemo after surgery. 

Genomic Health said that 26 percent of the prostate samples were classified as very low risk by its test, compared to only 5 to 10 percent for the existing methods. In some cases, however, the new test showed the cancer to be more aggressive than the existing methods.

Want the latest news on this?
Print This Page
  Search Website
Follow us on:
Follow us on Facebook Follow us on Twitter
Melatonin - self defence against cancer

CANCERactive Website Appeal
raised of £25,000 target

Click Here to donate

Select a donation amount:
Enter a donation amount:

Gift Aid:
So that CANCERactive can claim back 25p for every £1 donated, I confirm that I am a UK tax payer, who has paid over enough tax for you to reclaim this amount

Sign up for icon


Our icon magazine is available free in over 500 UK hospitals, cancer centres and libraries. Full of great articles and the very latest cancer information, you can have it sent to your own home.

Buy online

The CANCERactive Patient Group (CAPG) – Run by Patients, for Patients

  • Tell your Story
  • Start a Blog
  • Start a Diary Blog
  • Start a Discussion
  • Ask a Question

Search Drugs


Quick search for YOUR DRUG here  

Search Drugs


Quick search for a COMPLEMENTARY THERAPY here 

Search Complementary Therapies



Search Alternative Therapies

Important Notice

At CANCERactive we provide information that is already in the public domain.  It is not our intention to provide advice. It is up to the reader to decide if any of the matters to which any article refers might be suitable for them.


Follow CHRIS WOOLLAMS, the UK's number 1 cancer researcher, on his free e-news and keep right up to date with the very latest cancer information and research

 click here

  click here

click here


CANCERactive information and publications (books, magazine and leaflets)

CANCERactive compiled books

Heal Your Gut Heal Your Body

A real paradigm shift - this book will help you really understand exactly what to do to be in great health.

Click here to find out more.

The Brand new 4th edition of Everything You Need to Know to Help You Beat Cancer

"This book is head and shoulders above the rest". Geoffrey Boycott

Click here to find out more.

The Rainbow Diet - and how it can help you beat cancer

"At last the definitive book on a diet to fight cancer". Mrs BS Devon.

 Click here to find out more...

Brand new 3rd edition of Oestrogen The Killer in our Midst

"Learn how to take control of your oestrogen levels"

 Click here to find out more...

CANCERactive magazine (free in hospitals and complementary cancer centres)


Free downloadable prevention leaflets


Buy online

Donate to Us

We can only help people like you - if people like you help us!

Buy online

Fund Raising


Interested? Click here for more information

Click here to see all our fundraising events.

Click here and see what events are taking place and perhaps sponsor one of our supporters. 

Click here for other ways to raise money for CANCERactive.

Or if you want more information about our other fun activities, the Peru trek, our sky diving etc. click the button below.

Click here for our Just Giving page and see what our supporters are doing for us.

Click here for our Virgin Money Giving page.

Buy online

Visit a Catherine Corner

Catherine Wollams

Buy online

Need a Support Group?  

Find a cancer support group near you, now.
Buy online

So what is the truth behind mammograms, drug clinical trials, the PSA test and prostate surgery, and the stories you read in the press?Go to Junk Science to read the unbiased truth. Click Here.


Do you have a problem with our factual content?

If you have research which conflicts with ours, just address it to 'The Medical Board'. Ever since we started this site we have had an 'open-mind' policy and have expert oncology doctors and professors who will address your concerns.

© Copyright 2017 CANCERactive. All Rights Reserved. This content may be copied in full, with copyright, contact, creation and information intact, without specific permission, when used only in a not-for-profit format and provided, where used to publish on a website, that website provides a link to If any other use is desired, permission in writing from CANCERactive is required.
All content and images © Copyright 2017 - Website design and maintenance by a Web design and Search engine marketing company